Phylo, Inc. announced on August 4, 2026 that Chugai Pharmaceutical Co., Ltd. will deploy Biomni Lab, Phylo's agentic AI platform for biomedical research, across Chugai's drug discovery workflows in si…
Roche's divarasib beat Amgen's Lumakras and Bristol Myers Squibb's Krazati in a head-to-head Phase 3 trial for KRAS G12C non-small cell lung cancer, showing statistically significant improvements in p…
Anthropic CEO Dario Amodei tempered expectations for AI-driven scientific breakthroughs at the company's 'The Briefing: AI for Science' event, suggesting the 'compressed 21st century' he predicted mig…
Nvidia and Genentech executives made the case for AI-driven drug discovery at BIO2026, highlighting their partnership that combines Genentech's biological data with Nvidia's computing infrastructure. …